ReviewTherapeutics and clinical risk management2014

Profile of saxagliptin in the treatment of type 2 diabetes: focus on Japanese patients.

Hiroyuki Konya et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.